Medpace Holdings, Inc. (MEDP) — Business segments and KPIs
Revenue by business segment and geography for Medpace Holdings, Inc., with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Oncology | 747.59M | 29.5% |
| Metabolic | 744.96M | 29.4% |
| Other | 408.55M | 16.1% |
| Central Nervous System | 254.84M | 10.1% |
| Cardiology | 239.37M | 9.5% |
| Antiviral And Anti Infective | 134.94M | 5.3% |